Abstract | INTRODUCTION: METHODS: SSTR subtype (1, 2A, 3, 5) and CXCR4 expression was evaluated in G1 (n = 31), G2 (n = 47), and low (G3a; Ki-67: 21-49%; n = 21) and highly proliferative (G3b; Ki-67: >50%, n = 22) G3 (total n = 43) gastroenteropancreatic NEN samples by performing immunohistochemistry with monoclonal rabbit anti-human anti-SSTR and anti-CXCR4 antibodies, respectively, and was correlated with clinical data. RESULTS: Both CXCR4 and SSTR were widely expressed in all tumors investigated. CXCR4 expression differed significantly between the G1 and G3 specimens and within the G3 group (G3a to G3b), and was positively correlated with Ki-67 expression. SSTR2A, in contrast, exhibited an inverse association with Ki-67. SSTR2A was highly expressed in G1 and G2 tumors, but was significantly less abundant in G3 carcinomas. Additionally, SSTR1 expression was higher in G3a than in G3b tumors. CONCLUSION: We observed an elevation in CXCR4 and a decrease in SSTR2A expression with increasing malignancy. Interestingly, 23% of the G3 specimens had strong SSTR2A expression. Because CXCR4 was strongly expressed in highly proliferative G3 carcinomas, it is an interesting new target and needs to be validated in larger studies.
|
Authors | Daniel Kaemmerer, Tina Träger, Maike Hoffmeister, Bence Sipos, Merten Hommann, Jörg Sänger, Stefan Schulz, Amelie Lupp |
Journal | Oncotarget
(Oncotarget)
Vol. 6
Issue 29
Pg. 27566-79
(Sep 29 2015)
ISSN: 1949-2553 [Electronic] United States |
PMID | 26259237
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CXCR4 protein, human
- Ki-67 Antigen
- Receptors, CXCR4
- Receptors, Somatostatin
- Somatostatin
- somatostatin receptor 2
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Cell Proliferation
- Female
- Gastrointestinal Neoplasms
(metabolism)
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Ki-67 Antigen
(metabolism)
- Liver Neoplasms
(metabolism, secondary)
- Male
- Middle Aged
- Neoplasm Metastasis
- Neuroendocrine Tumors
(metabolism)
- Pancreatic Neoplasms
(metabolism)
- Receptors, CXCR4
(metabolism)
- Receptors, Somatostatin
(metabolism)
- Somatostatin
(metabolism)
- Treatment Outcome
|